InvestorsHub Logo
Followers 15
Posts 1333
Boards Moderated 0
Alias Born 07/27/2015

Re: None

Wednesday, 12/28/2016 5:59:48 PM

Wednesday, December 28, 2016 5:59:48 PM

Post# of 463759
Wheres Adam when you need him

Major finding: Aducanumab 10 mg/kg was associated with a near-stabilization of the MMSE score over 24 months in 15 patients in an open-label extension of a phase Ib study.

They complain about our 32 patient trial now down to 25 and Biogen reports one group taking 10mg when theres only 15 patients? Open label too


Bottom line: I guess they don't have something worth paying someone money to spread fud about.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News